Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevation Oncology (ELEV), Novartis AG (Six Swiss: CH:NOVN) and VBI Vaccines (VBIV)
TipRanksJul 19, 2023 05:04 ET
Raymond James Maintains Outperform on VBI Vaccines, Lowers Price Target to $6
BenzingaApr 13, 2023 09:25 ET
Raymond James Cuts Price Target on VBI Vaccines to $6 From $60, Maintains Outperform Rating
MT NewswiresApr 13, 2023 08:47 ET
VBI Vaccines Analyst Ratings
Benzinga Analyst RatingsNov 11, 2022 06:36 ET
Raymond James Downgrades VBI Vaccines to Outperform, Lowers Price Target to $2
Benzinga Real-time NewsNov 11, 2022 06:36 ET
VBI Vaccines Price Target Cut to $5.00/Share From $6.00 by Raymond James
Dow JonesAug 9, 2022 08:32 ET
VBI Vaccines Is Maintained at Strong Buy by Raymond James
Dow JonesAug 9, 2022 08:31 ET
VBI Vaccines analyst ratings
Benzinga Analyst RatingsAug 9, 2022 08:24 ET
Raymond James Maintains Strong Buy on VBI Vaccines, Lowers Price Target to $5
Benzinga Real-time NewsAug 9, 2022 08:24 ET
No Data
No Data